Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1980 1
1981 2
1982 1
1983 3
1984 3
1985 1
1986 1
1988 2
1989 1
1990 1
1991 1
1992 4
1993 2
1994 2
1996 6
1998 2
1999 1
2000 1
2001 2
2002 5
2003 4
2004 6
2005 1
2006 1
2007 2
2009 1
2013 1
2014 1
2017 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
Stimulatory transducing systems in pancreatic islet cells.
Emami S, Regnauld K, Ferrand N, Astesano A, Pessah M, Phan H, Boissard C, Garel JM, Rosselin G. Emami S, et al. Among authors: boissard c. Ann N Y Acad Sci. 1998 Dec 11;865:118-31. doi: 10.1111/j.1749-6632.1998.tb11170.x. Ann N Y Acad Sci. 1998. PMID: 9928004 Review.
Regulation of the vasoactive intestinal peptide receptor.
Rosselin G, Anteunis A, Astesano A, Boissard C, Gali P, Hejblum G, Marie JC. Rosselin G, et al. Among authors: boissard c. Ann N Y Acad Sci. 1988;527:220-37. doi: 10.1111/j.1749-6632.1988.tb26983.x. Ann N Y Acad Sci. 1988. PMID: 2839078 Review. No abstract available.
A role for sigma binding in the antipsychotic profile of BMY 14802?
Taylor DP, Eison MS, Moon SL, Schlemmer RF Jr, Shukla UA, VanderMaelen CP, Yocca FD, Gallant DJ, Behling SH, Boissard CG, et al. Taylor DP, et al. Among authors: boissard cg. NIDA Res Monogr. 1993;133:125-57. NIDA Res Monogr. 1993. PMID: 8232511 Review.
Pharmacological activation and inhibition of Slack (Slo2.2) channels.
Yang B, Gribkoff VK, Pan J, Damagnez V, Dworetzky SI, Boissard CG, Bhattacharjee A, Yan Y, Sigworth FJ, Kaczmarek LK. Yang B, et al. Among authors: boissard cg. Neuropharmacology. 2006 Sep;51(4):896-906. doi: 10.1016/j.neuropharm.2006.06.003. Epub 2006 Jul 28. Neuropharmacology. 2006. PMID: 16876206
Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain.
Wu YJ, Conway CM, Sun LQ, Machet F, Chen J, Chen P, He H, Bourin C, Calandra V, Polino JL, Davis CD, Heman K, Gribkoff VK, Boissard CG, Knox RJ, Thompson MW, Fitzpatrick W, Weaver D, Harden DG, Natale J, Dworetzky SI, Starrett JE Jr. Wu YJ, et al. Among authors: boissard cg. Bioorg Med Chem Lett. 2013 Nov 15;23(22):6188-91. doi: 10.1016/j.bmcl.2013.08.092. Epub 2013 Sep 8. Bioorg Med Chem Lett. 2013. PMID: 24070783
3-Thio-quinolinone maxi-K openers for the treatment of erectile dysfunction.
Boy KM, Guernon JM, Sit SY, Xie K, Hewawasam P, Boissard CG, Dworetzky SI, Natale J, Gribkoff VK, Lodge N, Starrett JE Jr. Boy KM, et al. Among authors: boissard cg. Bioorg Med Chem Lett. 2004 Oct 18;14(20):5089-93. doi: 10.1016/j.bmcl.2004.07.080. Bioorg Med Chem Lett. 2004. PMID: 15380205
3-[(5-Chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl ]-1,3,4-oxadiazol-2(3H)-one, BMS-191011: opener of large-conductance Ca(2+)-activated potassium (maxi-K) channels, identification, solubility, and SAR.
Romine JL, Martin SW, Meanwell NA, Gribkoff VK, Boissard CG, Dworetzky SI, Natale J, Moon S, Ortiz A, Yeleswaram S, Pajor L, Gao Q, Starrett JE Jr. Romine JL, et al. Among authors: boissard cg. J Med Chem. 2007 Feb 8;50(3):528-42. doi: 10.1021/jm061006n. J Med Chem. 2007. PMID: 17266205
62 results